the Norwegian Academy of Science and Letters from 1976. In 1996, he was made a Companion of Honour (CH) for "services of national importance". International honours included the Presidential Award of the New York Academy of Sciences as well as a United Nations Award for his research into cancer. In April 2005, he was awarded the Saudi Arabian King Faisal International Prize for medicine jointly with Peto for their work on diseases related to smoking. In 2004, he was awarded the inaugural Shaw Prize for Life Sciences and Medicine for his contribution to modern cancer epidemiology. He was also awarded honorary degrees by thirteen different universities. He was a supporter of the Liberal Democrats at the 2005 general election. Death He died on 24 July 2005, at the John Radcliffe Hospital in Oxford after a short illness. On 7 June 2015, a blue plaque was unveiled at his home at 12 Rawlinson Road. Although raised in a Jewish family, he was an atheist. Building The Richard Doll Building in Headington, east Oxford, designed by Nicholas Hare Architects in 2006, was named in his honour and opened shortly before his death. It houses the Clinical Trial Service Unit, Cancer Epidemiology Unit and National Perinatal Epidemiology Unit. The building received an RIBA Award in 2007. A plaque inside the building contains the following quotation from Doll: One of the buildings of the Institute of Cancer Research in Sutton, London is also named after Sir Richard Doll. Research funding After Richard Doll's death, some controversy arose over aspects of his research funding when his papers, held at the Wellcome Library, indicated that for many years he had received consultancy payments from chemical companies whose products he was to defend in court. These include US$1,500 per day consultancy fee from the Monsanto Company for a relationship which began in 1976 and continued until 2002. During this period Doll wrote to a Royal Commission in Australia investigating whether the Monsanto-produced herbicide Agent Orange, which was used during the Vietnam War, was carcinogenic, claiming that there was no evidence that it caused cancer. He also received £15,000 from the Chemical Manufacturers Association, Dow Chemicals, and ICI for a review published in 1988 that concluded that workplace exposure to vinyl chloride did not increase the chance of contracting cancer, with the exception of angiosarcoma of the liver, contradicting two previous reviews by the World Health Organization's International